Vault complexes for cytokine delivery
The invention relates to compositions of vault complexes containing recombinant cytokine fusion proteins that include a cytokine and a vault targeting domain, and methods of using the vault complexes to deliver the cytokines to a cell or subject, and methods for using the compositions to treat cancer, such as lung cancer.
1. An isolated nucleic acid encoding a fusion protein, said fusion protein comprising a major vault protein interaction domain (mINT) fused to a cytokine, comprising a cytokine encoding sequence and a ml NT encoding sequence that encodes SEQ ID NO:8 (human) or SEQ ID NO:9 (mouse).
2. The isolated nucleic acid of claim 1 , wherein the mINT encoding sequence comprises the nucleic acid sequence of SEQ ID NO:7 (human) or SEQ ID NO:6 (mouse).
3. The isolated nucleic acid of claim 1 , wherein (a) the cytokine encoding sequence consists of the nucleic acid sequence of SEQ ID NO:5 (human) and the mINT encoding sequence consists of the nucleic acid sequence of SEQ ID NO:7 (human), or (b) the cytokine encoding sequence consists of the nucleic acid sequence of SEQ ID NO:3 (mouse) and the mINT encoding sequence consists of the nucleic acid sequence of SEQ ID NO:6 (mouse).
4. The isolated nucleic acid of claim 1 , wherein the cytokine fusion protein comprises the nucleic acid sequence of SEQ ID NO:11 (human), SEQ ID NO: 10 (mouse), or SEQ ID NO:62 (mouse).
5. A vector comprising the isolated nucleic acid of claim 1 .
6. The vector of claim 5 , wherein the vector is a baculovirus expression vector.
7. A cell comprising the nucleic acid of claim 1 or a vector comprising the nucleic acid of claim 1 .
8. A composition comprising a vault complex comprising a fusion protein, wherein the fusion protein comprises a major vault protein interaction domain (mINT) fused to a cytokine, and wherein the fusion protein is encoded by the isolated nucleic acid according to claim 1 .
9. The composition of claim 8 , wherein the cytokine comprises the amino acid sequence of SEQ ID NO:2 (human) or SEQ ID NO:1 (mouse).
10. The composition of claim 8 , wherein the fusion protein comprises the amino acid sequence of SEQ ID NO:13 (human) or SEQ ID NO: 12 (mouse).
11. The composition of claim 8 , further comprising a vault poly ADP-ribose polymerase (VPARP), a telomerase vault associated protein 1 (TEP1), or an untranslated RNA molecule (vRNA).
12. The composition of claim 8 , wherein the fusion protein further comprises a fluorescent protein.